Literature DB >> 2002574

Coronary thrombolysis for the elderly?

J H Gurwitz1, R J Goldberg, J M Gore.   

Abstract

Mesh：

Year:  1991        PMID： 2002574

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  15 in total

1.  Current and Practical Management of Acute Myocardial Infarction.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

Review 2.  Thrombolytic therapy in acute myocardial infarction.

Authors:  U Priglinger; K Huber
Journal:  Drugs Aging       Date:  2000-04       Impact factor: 3.923

3.  Thrombolytic treatment for elderly patients.

Authors:  A T Elder; K A Fox
Journal:  BMJ       Date:  1992-10-10

Review 4.  Thrombolytic therapy in the elderly. Pharmacoeconomic considerations.

Authors:  K Ramanathan; C J Ellis; H D White
Journal:  Drugs Aging       Date:  1996-04       Impact factor: 3.923

5.  ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors:  C Baigent; R Collins; P Appleby; S Parish; P Sleight; R Peto
Journal:  BMJ       Date:  1998-05-02

6.  Thrombolysis for stroke in the elderly.

Authors:  Bijan Vatankhah; Michael S Dittmar; Nando P Fehm; Petr Erban; Guntram W Ickenstein; Wolfgang Jakob; Ulrich Bogdahn; Markus Horn
Journal:  J Thromb Thrombolysis       Date:  2005-08       Impact factor: 2.300

Review 7.  Does the potential for development of streptokinase antibodies change the risk-benefit ratio in older patients?

Authors:  J Brügemann; P A de Graeff; J van der Meer; K I Lie
Journal:  Drugs Aging       Date:  1995-08       Impact factor: 3.923

Review 8.  Optimising thrombolytic therapy in elderly patients with acute myocardial infarction.

Authors:  M Verstraete; D Collen
Journal:  Drugs Aging       Date:  1996-01       Impact factor: 3.923

9.  Age-associated vascular oxidative stress, Nrf2 dysfunction, and NF-{kappa}B activation in the nonhuman primate Macaca mulatta.

Authors:  Zoltan Ungvari; Lora Bailey-Downs; Tripti Gautam; Danuta Sosnowska; Mingyi Wang; Robert E Monticone; Richard Telljohann; John T Pinto; Raphael de Cabo; William E Sonntag; Edward G Lakatta; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-05-28       Impact factor: 6.053

10.  Safe use of streptokinase in myocardial infarction in patients aged 75 and over.

Authors:  K Kafetz; R Luder
Journal:  Postgrad Med J       Date:  1992-09       Impact factor: 2.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.